Ocular Therapeutix (NASDAQ:OCUL) Cut to “Sell” at StockNews.com

StockNews.com lowered shares of Ocular Therapeutix (NASDAQ:OCUL – Free Report) from a hold rating to a sell rating in a report released on Sunday morning. OCUL has been the topic of several other research reports. HC Wainwright reissued a buy rating and set a $12.00 target price on shares of Ocular Therapeutix in a research […]

Leave a Reply

Your email address will not be published.

Previous post Western Asset Mortgage Capital (NYSE:WMC) Receives New Coverage from Analysts at StockNews.com
Next post The All-New Chevrolet Corvette E-Ray: A Powerful Hybrid with Electrified Prowess